167 related articles for article (PubMed ID: 10190092)
21. Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during short-term gamma-irradiation.
Luksa-Lichtenthaeler GL; Ladutko EI; Nowicky JW
Drugs Exp Clin Res; 2000; 26(5-6):311-5. PubMed ID: 11345044
[TBL] [Abstract][Full Text] [Related]
22. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
23. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
[TBL] [Abstract][Full Text] [Related]
24. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part III: Effect on the native electron paramagnetic resonance signal intensity of the femur.
Jabłoński M; Korczak W; Gorzelak M; Jagiełło-Wójtowicz E
Drugs Exp Clin Res; 2000; 26(5-6):333-6. PubMed ID: 11345048
[TBL] [Abstract][Full Text] [Related]
25. Ukrain both as an anti cancer and immunoregulatory agent.
Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
[TBL] [Abstract][Full Text] [Related]
26. The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy.
Svechnikova IG; Korolenko TA; Stashko JuF ; Kaledin VI; Nikolin VP; Nowicky JW
Drugs Exp Clin Res; 1998; 24(5-6):261-9. PubMed ID: 10190085
[TBL] [Abstract][Full Text] [Related]
27. Influence of Ukrain on the redox processes of hepatocytes.
Zhalilo LI; Susak YM; Zemskov SV; Susak IA
Drugs Exp Clin Res; 1996; 22(3-5):189-91. PubMed ID: 8899328
[TBL] [Abstract][Full Text] [Related]
28. Ukrain therapy of stage T1N0M0 bladder cancer patients.
Uglianitsa KN; Nechiporenko NA; Nefyodov LI; Brzosko WJ
Drugs Exp Clin Res; 1998; 24(5-6):227-30. PubMed ID: 10190079
[TBL] [Abstract][Full Text] [Related]
29. Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice.
Grinevich Y; Shalimov S; Bendyuh G; Zahriychuk O; Hodysh Y
Drugs Exp Clin Res; 2005; 31(2):59-70. PubMed ID: 15929607
[TBL] [Abstract][Full Text] [Related]
30. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
[TBL] [Abstract][Full Text] [Related]
31. A study of the influence of a novel drug Ukrain on in vivo effects of low-dose ionizing radiation.
Boyko VN; Levshina YeV
Drugs Exp Clin Res; 1998; 24(5-6):339-41. PubMed ID: 10190100
[TBL] [Abstract][Full Text] [Related]
32. Effect of intermittent three-month treatment with different doses of Ukrain on subregional bone mineral density of the femur of ovariectomized rats.
Jabłoński M; Gorzelak M; Patyra M; Jagiello-Wójtowicz E
Drugs Exp Clin Res; 1998; 24(5-6):317-20. PubMed ID: 10190095
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological effects of Ukrain in rats and rabbits.
Remiszewska M; Wutkiewicz M; Jastrzebski Z; Czyzewska-Szafran H; Danysz A
Acta Pol Pharm; 1992; 49(4):43-5. PubMed ID: 16092434
[TBL] [Abstract][Full Text] [Related]
34. The effect of NSC-631570 (ukrain) alone and in combination with pathogen-associated molecules on cell cycle distribution and apoptosis induction of mouse melanoma cells with different biological properties.
Skivka LM; Trompak OO; Kudryavets YI; Bezdenezhnykh NA; Susak YM
Exp Oncol; 2010 Jul; 32(2):92-6. PubMed ID: 20693969
[TBL] [Abstract][Full Text] [Related]
35. Mitogenic properties of Ukrain (NSC-6315170) on human peripheral blood monocytes: clinical implications.
Jin YM; Nowicky JW; Liepins A
Drugs Exp Clin Res; 1996; 22(3-5):99-101. PubMed ID: 8899311
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. Report 1. Clinical aspects of Ukrain application.
Uglyanitsa KN; Nefyodov LI; Brzosko V
Drugs Exp Clin Res; 2000; 26(5-6):223-30. PubMed ID: 11345029
[TBL] [Abstract][Full Text] [Related]
37. Amino acids and their derivatives in tumour tissue from patients with breast cancer treated with Ukrain. Part VI.
Nefyodov LI; Uglyanica KN; Smirnov VY; Doroshenko YM; Fomin KA; Nowicky JW; Brzosko WJ
Drugs Exp Clin Res; 1996; 22(3-5):159-61. PubMed ID: 8899321
[TBL] [Abstract][Full Text] [Related]
38. Some pharmacological properties of prolonged administration of Ukrain in rodents.
Kleinrok Z; Jagiełł-Wójtowicz E; Nowicky JW; Chodkowska A; Feldo M; Matuszek B
Drugs Exp Clin Res; 1992; 18 Suppl():93-6. PubMed ID: 1284807
[TBL] [Abstract][Full Text] [Related]
39. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part II: Effect on bone mineral density of the femur.
Jabłoński M; Gorzelak M; Patyra M; Jagiełło-Wójtowicz E
Drugs Exp Clin Res; 2000; 26(5-6):327-31. PubMed ID: 11345047
[TBL] [Abstract][Full Text] [Related]
40. Ukrain treatment of rhabdomyosarcoma (case report).
Kotsay B; Lisnyak O; Myndiuk O; Romanys-hyn J; Fabri O
Drugs Exp Clin Res; 1996; 22(3-5):239-41. PubMed ID: 8899339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
